NEWS & PERSPECTIVES
Psychedelics News
Curated updates on microdosing, research, policy, and community.
The latest
We Are Done With Shamans Behaving Badly
Abuse in psychedelic ceremonies is more common than the community admits. Here's what it looks like and how to protect yourself. [...] Read More... The post We Are Done With Shamans Behaving Badly appeared first on Do...
A single dose of psilocybin eased depression symptoms for months, our study found
Our trial found psilocybin worked fast and lasted months, but unpicking the drug’s true effect from patients’ expectations remains a challenge.
Music Selection in Psychedelic Sessions: The Dynamics of Choosing What’s Played
Music profoundly shapes psychedelic experiences, and thoughtful playlist curation – considering setting, emotional intent, familiarity, and the journey’s stages – is key to a safe and meaningful session. The post Musi...
Psychedelics vs Antidepressants: What a New Meta-Analysis Really Shows
The headline is hard to miss: “Psychedelics may be no better than antidepressants for depression,” as reported by New Scientist (Busby, 2026). For those following psychedelic research with hope (and for the field itse...
Beyond the Ceremony: Training, Community, and Principles for Ayahuasca Facilitators
Smoother retreats, solid protocols, world-class instructors, and a community of practice. What facilitators gain from AyaSafety, the leading ayahuasca safety course by ICEERS. 2026 enrollment closes May 25.
Psychedelics & Autism Spectrum Disorder (ASD): What to Know
In reviewing the most up-to-date anecdotal reports, preclinical, and clinical research, we find promising results, showing that psychedelics might have potential to mitigate social anxiety and cognitive rigidity in ad...
What Happens When You Feel Like Jesus After Taking Psychedelics?
Experts explain why some psychedelic trips end in claims of divinity — and when it becomes a problem. [...] Read More... The post What Happens When You Feel Like Jesus After Taking Psychedelics? appeared first on Doub...
Truffles, therapy, disciplinary law – An OPEN perspective on the grey area in which (licensed) therapists operate in the Netherlands with regard to psychedelics
Read this article in Dutch here. On May 8, 2026, the Amsterdam Healthcare Disciplinary Board ruled on a significant case in which the Health and Youth Care Inspectorate (IGJ) had filed a complaint against a clinical p...
How sharing a psychedelic experience changes romantic relationships
Taking psychedelics alongside a romantic partner is linked to a deeper mutual understanding and improved relationship satisfaction. Conversely, undertaking an intense psychedelic journey alone might leave couples out ...
LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a Phase 2a trial
Repeated microdosing of LSD (8 to 20 μg) may help improve daily mood, specifically increasing feelings of connection, creativity, and energy in people with major depressive disorder.
It’s all about the relationship: The caregiver experience of supporting a person with advanced cancer going through an LSD microdosing trial
Caregivers of people with advanced cancer often find that psychedelic-assisted therapy can strengthen their relationships and provide a sense of hope during difficult times.
Epidemiology of Hallucinogen Microdosing Among Young Adults in the United States: A National Study
About 1 in 15 young adults in the United States reported microdosing hallucinogens in the past year.
Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial
Low doses of psilocybin may reduce the frequency of migraine attacks, but a two-dose "pulsed" schedule did not show a significant advantage over a single dose in this trial.
Microdosing psychedelics and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials
Microdosing psilocybin can improve the quality of creative thinking by helping people come up with more original ideas.
What is it like to microdose LSD for depression? a thematic analysis of participant interviews from an open-label trial
Participants with major depressive disorder reported feeling more motivated, more connected to others, and better able to process emotions during an eight-week LSD microdosing trial.